Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 7;23(1):17.
doi: 10.1186/s12575-021-00154-8.

Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis

Affiliations

Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis

Wei Feng et al. Biol Proced Online. .

Erratum in

Abstract

Aims: We focused on the detailed functions of circ-ABCB10 in cervical cancer (CC) development and its mechanisms.

Background: The increasing findings have proposed the central roles of circular RNAs (circRNAs) in the tumorigenesis of various human cancers. Circ-ABCB10 displays promising oncogenic effect in several tumors.

Methods: Circ-ABCB10 and miR-128-3p production levels in CC tissues and cells were tested through RT-qPCR. The association of circ-ABCB10 expression with clinicopathologic parameters of CC patients was statistically analyzed. Cell proliferation, invasion, apoptosis, and epithelial-mesenchymal transition (EMT) were evaluated by MTT, transwell invasion assays, flow cytometry analyses, and western blot examination of EMT markers. The binding activity between miR-128-3p and circ-ABCB10 or zinc finger E-box binding homeobox 1 (ZEB1) was explored through pull-down assay or luciferase reporter assay. The influence of circ-ABCB10 on CC tumorigenesis was evaluated by in vivo xenograft experiments.

Results: The elevated circ-ABCB10 expression was determined in CC tissues and cells. Moreover, higher production level of circ-ABCB10 was close related to lymph-node metastasis, Federation of Gynecology and Obstetrics (FIGO) stage, and tumor size in CC patients. Loss of circ-ABCB10 weakened cell proliferative and invasive abilities, inhibited EMT, and induced apoptosis in CC. Loss of circ-ABCB10 inhibited ZEB1 expression by serving as a sponge of miR-128-3p in CC cells. Circ-ABCB10 sponged miR-128-3p to enhance cell proliferation, invasion, EMT and inhibit apoptosis in CC cells. Xenograft tumor assays confirmed that circ-ABCB10 knockdown inhibited CC tumor growth.

Conclusion: Our study suggests that circ-ABCB10 depletion inhibits proliferation, invasion and EMT and promotes apoptosis of cervical cancer cells through miR-128-3p/ZEB1 axis and represses CC tumor growth.

Keywords: Apoptosis; Cervical cancer; Circ-ABCB10; Invasion; Proliferation; ZEB1; miR-128-3p.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing or financial interests.

Figures

Fig. 1
Fig. 1
Circ-ABCB10 expression analyses in CC tissues and cells. A-C Circ-ABCB10 expression levels were examined by RT-qPCR assays in CC tissues and adjacent normal tissues (A), CC tumors with different size (B), 5 CC cell lines and a normal cervical cell line (C). *P < 0.05
Fig. 2
Fig. 2
Loss of circ-ABCB10 suppressed cell proliferation, invasion and EMT and induced apoptosis in CC cells. A-E Hela and C33A cells were infected with sh-Ctrl or sh-circ-ABCB10 lentiviruses. A Circ-ABCB10 expression levels were examined through qRT-PCR method. B Cell proliferative activity was estimated through MTT assays. C Cell invasive ability was assessed through transwell invasion assays. D E-cadherin, N-cadherin, Vimentin, and Snail production levels were measured through western blotting assays. E Apoptosis was assessed using flow cytometry analyses. *P < 0.05
Fig. 3
Fig. 3
Circ-ABCB10 served as a molecular sponge of miR-128-3p in CC cells. A Putative complementary sites between circ-ABCB10 and miR-128-3p. B Luciferase activities were measured at 48 h post transfection. C The interaction between circ-ABCB10 and miR-128-3p in cells was further confirmed by pull-down assays. D The levels of miR-128-3p in CC tissues (n = 34) by RT-qPCR assay. E A negative correlation between miR-128-3p and circ-ABCB10 expressions in CC tissues. F MiR-128-3p level was determined by RT-qPCR assay in CC cells. G The effects of circ-ABCB10 loss or overexpression on miR-128-3p expression were tested through RT-qPCR assays. *P < 0.05
Fig. 4
Fig. 4
miR-128-3p curbed cell proliferation, invasion, and EMT and promoted cell apoptosis and circ-ABCB10 reversed those effects in CC. A MiR-128-3p levels were examined through RT-qPCR assays in Hela and C33A cells infected with miR-128-3p or miR-Ctrl lentiviruses. B-E Hela and C33A cells were infected with miR-128-3p or miR-Ctrl along with control or circ-ABCB10 lentiviruses, followed by the detection of cell proliferative (B) and invasive (C) abilities, EMT marker expression levels (D) and cell apoptotic rate (E). *P < 0.05
Fig. 5
Fig. 5
Circ-ABCB10 promoted ZEB1 expression by acting as a molecular sponge of miR-128-3p in CC cells. A Putative binding sites between miR-128-3p and ZEB1 3’UTR. B Luciferase activities were measured at 48 h after transfection. C ZEB1 protein levels were examined through western blotting assays at 48 h after transfection. *P < 0.05
Fig. 6
Fig. 6
ABCB10 depletion inhibited the growth and EMT of CC xenograft tumors via miR-128-3p/ZEB1 axis. Mice were randomly divided into sh-ctrl or sh-circ-ABCB10 group with 6 mice per group. C33A cells stably transduced with sh-ctrl or sh-circ-ABCB10 lentiviruses were inoculated into the subcutaneous tissues of mice in sh-ctrl or sh-circ-ABCB10 group, respectively. A The tumor volume was monitored and recorded every 5 days. B At day 30, tumors were resected and weighed. C IHC analyses for Ki67 in xenograft tumors in sh-Ctrl and sh-circ-ABCB10 groups. D MiR-128-3p levels were tested through RT-qPCR assays in xenograft tumors. E ZEB1, E-cadherin, N-cadherin, Vimentin and Snail in xenograft tumors production levels were examined through western blotting assays. *P < 0.05

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Vu M, Yu J, Awolude OA, et al. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–465. doi: 10.1016/j.currproblcancer.2018.06.003. - DOI - PubMed
    1. Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer. Lancet. 2019;393(10167):169–182. doi: 10.1016/S0140-6736(18)32470-X. - DOI - PubMed
    1. Wolford JE, Tewari KS. Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer. Expert Opin Drug Discov. 2018;13(5):445–457. doi: 10.1080/17460441.2018.1443074. - DOI - PMC - PubMed
    1. Balasubramaniam SD, Balakrishnan V, Oon CE. Key molecular events in cervical cancer development. Medicina. 2019;55(7):384. doi: 10.3390/medicina55070384. - DOI - PMC - PubMed